New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Alzamend Neuro, Inc. (ALZN) vs Pulmatrix, Inc. (PULM)
- Alzamend Neuro, Inc. ALZN 1.02 −1.92%
- Pulmatrix, Inc. PULM 1.40 +4.48%
Alzamend Neuro, Inc. and Pulmatrix, Inc. are both Biotechnology companies. Alzamend Neuro, Inc. and Pulmatrix, Inc. are of similar size ($4.9M and $4.9M). Across the 9 metrics below, Alzamend Neuro, Inc. leads on 5 and Pulmatrix, Inc. on 4.
Valuation
Profitability
| Metric | ALZN | PULM | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 70.18% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (163.23%) | (172.27%) | (51.58%) |
| Return on assets | (122.36%) | (119.43%) | (45.91%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack